Presentation Information
[NFS-03-1]Research priorities to understand the role of alpha-Synuclein in Parkinson's disease
Stella M. Papa (Emory University, USA)
Stella M. Papa, M.D. is a Professor at the Department of Neurology, Emory University School of Medicine, and Core Scientist at Emory National Primate Research Center. She completed her studies in Medicine (M.D.) at National University of Buenos Aires, Argentina, and her post-doctoral trainings at University of Navarra, Spain, and NINDS, National Institutes of Health, Bethesda, Maryland, USA. Dr. Papa leads a research team dedicated to experimental therapeutics for Parkinson’s disease (PD) and Movement Disorders. Her research for PD is focused on improving the sensorimotor network function through the regulation of striatal circuits, as well as halting the progression of neurodegeneration through targeting disease mechanisms. Dr. Papa’s laboratory uses genetic, electro-physiological, and pharmacological strategies to manipulate mechanisms in vivo with temporal precision and cellular resolution. She uses rodents and primates to model PD pathology for studies for disease-modifying therapies. Her work is based on multidisciplinary projects with collaborations worldwide, such as Stanford University (US), Osaka University (Japan), Universita Cattolica del Sacro Cuore (Italy). Dr. Papa chairs the Emory University Research Committee for Biological and Health Sciences. Dr. Papa has served in multiple national and international scientific review panels and contributed to various scientific societies chairing committees and panel of experts.